Go Pro

Phathom Pharmaceuticals (PHAT) Institutional Ownership

Phathom Pharmaceuticals logo
$12.06 +0.51 (+4.42%)
Closing price 04:00 PM Eastern
Extended Trading
$11.77 -0.29 (-2.40%)
As of 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Phathom Pharmaceuticals (NASDAQ:PHAT)

Current
Institutional Ownership
Percentage
99.01%
Number of
Institutional Buyers
(last 12 months)
104
Total
Institutional Inflows
(last 12 months)
$186.96M
Number of
Institutional Sellers
(last 12 months)
42
Total
Institutional Outflows
(last 12 months)
$92.93M
Get PHAT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Phathom Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PHAT Institutional Buying and Selling by Quarter

Phathom Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/3/2026NewEdge Advisors LLC183,000$2.03M0.0%-8.9%0.229%
5/29/2026Perceptive Advisors LLC925,000$10.28M0.2%N/A1.160%
5/28/2026Avidity Partners Management LP249,390$2.77M0.6%+21.0%0.313%
5/19/2026NewEdge Advisors LLC183,000$2.03M0.0%-8.9%0.229%
5/19/2026Bank of America Corp DE208,115$2.31M0.0%-19.6%0.261%
5/18/2026Royal Bank of Canada5,766$64K0.0%-74.4%0.007%
5/18/2026EcoR1 Capital LLC625,000$6.94M0.3%N/A0.784%
5/16/2026Quantinno Capital Management LP11,536$128K0.0%N/A0.014%
5/16/2026SummitTX Capital L.P.995,885$11.06M0.3%+92.3%1.249%
5/16/2026Lazard Asset Management LLC14,671$163K0.0%N/A0.018%
5/14/2026Renaissance Technologies LLC305,800$3.40M0.0%N/A0.383%
5/14/2026State of Wyoming4,936$55K0.0%N/A0.006%
5/7/2026KBC Group NV77,139$857K0.0%N/A0.097%
5/7/2026Swiss National Bank92,600$1.03M0.0%+10.2%0.116%
5/6/2026Kera Capital Partners Inc.26,826$298K0.0%+10.6%0.034%
5/5/2026Bank of New York Mellon Corp124,018$1.38M0.0%+0.9%0.155%
4/30/2026Summit Securities Group LLC3,048$34K0.0%N/A0.004%
4/27/2026Simplify Asset Management Inc.262,386$2.92M0.0%-18.5%0.330%
4/27/2026Private Advisor Group LLC10,180$113K0.0%-30.2%0.013%
4/21/2026Wasatch Advisors LP1,340,916$14.90M0.1%+0.7%1.688%
2/23/2026Kera Capital Partners Inc.24,255$402K0.1%-19.3%0.034%
2/23/2026Virtu Financial LLC15,540$258K0.0%N/A0.022%
2/19/2026Invesco Ltd.3,920,446$65.04M0.0%+1.4%5.489%
2/18/2026XTX Topco Ltd39,400$654K0.0%-27.8%0.055%
2/18/2026VARCOV Co.86,759$1.44M0.6%N/A0.121%
2/18/2026Virtus Investment Advisers LLC46,937$779K0.2%+5.9%0.066%
2/18/2026Wellington Management Group LLP134,546$2.23M0.0%-8.1%0.188%
2/18/2026SummitTX Capital L.P.517,820$8.59M0.3%+34.2%0.725%
2/18/2026Tudor Investment Corp ET AL28,554$474K0.0%-16.2%0.040%
2/18/2026Millennium Management LLC2,082,180$34.54M0.0%-59.0%2.915%
2/18/2026Janus Henderson Group PLC21,500$357K0.0%N/A0.030%
2/18/2026Engineers Gate Manager LP44,258$734K0.0%N/A0.062%
2/18/2026Catalio Capital Management LP698,996$11.60M2.1%-38.1%0.979%
2/18/2026Balyasny Asset Management L.P.207,085$3.44M0.0%-29.8%0.290%
2/18/2026683 Capital Management LLC1,785,000$29.61M1.3%-1.9%2.499%
2/18/20269823 Capital L.P.10,429$173K0.1%N/A0.015%
2/17/2026Schonfeld Strategic Advisors LLC30,944$513K0.0%N/A0.043%
2/17/2026AQR Capital Management LLC54,448$903K0.0%+3.5%0.076%
2/17/2026Jain Global LLC21,737$361K0.0%N/A0.030%
2/17/2026Trexquant Investment LP136,824$2.27M0.0%+75.0%0.192%
Porter flew 3,300 miles to investigate this system (Ad)

Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel

Watch the full investigation and decide for yourself
2/17/2026Jump Financial LLC17,408$289K0.0%N/A0.024%
2/17/2026Price T Rowe Associates Inc. MD37,071$616K0.0%+16.1%0.052%
2/17/2026California State Teachers Retirement System40,143$666K0.0%+1,288.6%0.056%
2/17/2026State of Wisconsin Investment Board15,285$254K0.0%N/A0.021%
2/17/2026ExodusPoint Capital Management LP22,401$372K0.0%-68.6%0.031%
2/17/2026Royal Bank of Canada22,554$374K0.0%-86.1%0.032%
2/17/2026Graham Capital Management L.P.12,867$213K0.0%N/A0.018%
2/17/2026Persistent Asset Partners Ltd12,916$214K0.1%N/A0.018%
2/16/2026Next Century Growth Investors LLC393,774$6.53M0.5%N/A0.551%
2/16/2026Entropy Technologies LP11,000$182K0.0%N/A0.015%
2/16/2026Avidity Partners Management LP206,076$3.42M1.0%-32.7%0.289%
2/16/2026Barclays PLC84,859$1.41M0.0%-33.9%0.119%
2/13/2026Kestra Advisory Services LLC2,275$38K0.0%N/A0.003%
2/13/2026The Manufacturers Life Insurance Company 12,438$206K0.0%-14.9%0.017%
2/13/2026CANADA LIFE ASSURANCE Co6,818$113K0.0%N/A0.010%
2/13/2026Stifel Financial Corp51,661$857K0.0%+160.0%0.072%
2/13/2026Southeast Asset Advisors LLC42,874$711K0.1%N/A0.060%
2/13/2026Bridgefront Capital LLC16,981$282K0.1%N/A0.024%
2/13/2026Rafferty Asset Management LLC13,855$230K0.0%N/A0.019%
2/13/2026Birchview Capital LP195,000$3.24M1.9%+129.4%0.273%
2/13/2026Charles Schwab Investment Management Inc.397,910$6.60M0.0%+8.7%0.557%
2/13/2026State Street Corp1,149,536$19.07M0.0%+9.1%1.610%
2/13/2026Caitong International Asset Management Co. Ltd1,606$27K0.1%N/A0.002%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC30,631$508K0.0%N/A0.043%
2/13/2026Wells Fargo & Company MN68,016$1.13M0.0%+26.8%0.095%
2/12/2026Wasatch Advisors LP1,331,669$22.09M0.1%-13.4%1.865%
2/12/2026HRT Financial LP27,010$448K0.0%+19.9%0.038%
2/12/2026Tocqueville Asset Management L.P.34,700$576K0.0%+40.5%0.049%
2/12/2026Ensign Peak Advisors Inc2,352,020$39.02M0.1%-6.0%3.293%
2/12/2026New York State Common Retirement Fund41,756$693K0.0%+287.7%0.058%
2/12/2026Campbell & CO Investment Adviser LLC115,284$1.91M0.1%N/A0.161%
2/12/2026Swiss National Bank84,000$1.39M0.0%N/A0.118%
2/12/2026Nuveen LLC108,846$1.81M0.0%-1.1%0.152%
2/11/2026Deutsche Bank AG33,380$554K0.0%+12.9%0.047%
2/11/2026GW&K Investment Management LLC1,306,678$21.68M0.2%+14.2%1.830%
2/11/2026Fox Run Management L.L.C.20,487$340K0.1%N/A0.029%
2/11/2026JPMorgan Chase & Co.296,684$4.92M0.0%+116.6%0.415%
2/11/2026Los Angeles Capital Management LLC33,425$555K0.0%N/A0.047%
2/11/2026Propel Bio Management LLC740,918$12.29M10.5%+34.0%1.037%
2/10/2026Goldman Sachs Group Inc.392,045$6.50M0.0%+157.9%0.549%
2/10/2026AXQ Capital LP10,540$175K0.0%-46.9%0.015%
2/10/2026Catalys Pacific LLC1,429,014$23.71M7.6%+22.4%2.001%
2/10/2026Intech Investment Management LLC19,051$316K0.0%-11.6%0.027%
2/9/2026Geode Capital Management LLC1,073,434$17.81M0.0%-1.4%1.503%
2/6/2026GSA Capital Partners LLP82,624$1.37M0.1%+17.6%0.116%
2/6/2026ProShare Advisors LLC10,377$172K0.0%N/A0.015%
2/5/2026Baader Bank Aktiengesellschaft15,000$249K0.0%N/A0.021%
2/5/2026Allworth Financial LP10,450$173K0.0%-48.9%0.015%
2/2/2026Hussman Strategic Advisors Inc.147,000$2.44M0.6%N/A0.206%
1/29/2026UBS Group AG304,383$5.05M0.0%-10.0%0.426%
Is the fix for AI's runaway power problem your golden ticket? (Ad)

The government just committed $200 billion to building computer chips on American soil - one of the largest technology bets in U.S. history. George Gilder, who has tracked technology signals for over 40 years, believes Washington just tipped its hand. He says this move points to a coming shift in computing that could leave today's machines behind - and most investors have already moved past the headline.tc pixel

See the signal George Gilder is reading before the market catches on
1/29/2026Vanguard Group Inc.3,177,211$52.71M0.0%-1.2%4.449%
1/29/2026China Universal Asset Management Co. Ltd.11,592$192K0.0%-6.8%0.016%
1/28/2026Arizona State Retirement System11,867$197K0.0%N/A0.017%
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank19,890$330K0.0%N/A0.028%
1/20/2026Stratos Wealth Partners LTD.50,300$834K0.0%N/A0.070%
1/14/2026Hennion & Walsh Asset Management Inc.114,981$1.91M0.1%N/A0.161%
1/9/2026SG Americas Securities LLC16,497$274K0.0%N/A0.023%
1/9/2026 Inspirion Wealth Advisors LLC19,814$329K0.0%-45.9%0.028%
1/1/2026JPMorgan Chase & Co.136,948$1.61M0.0%-1.1%0.193%
1/1/2026Tudor Investment Corp ET AL34,090$401K0.0%N/A0.048%


PHAT Institutional Ownership - Frequently Asked Questions

During the previous two years, 162 institutional investors and hedge funds held shares of Phathom Pharmaceuticals. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($119.55M), Invesco Ltd. ($65.04M), Vanguard Group Inc. ($52.71M), Jennison Associates LLC ($44.16M), Ensign Peak Advisors Inc ($39.02M), Millennium Management LLC ($34.54M), and Portolan Capital Management LLC ($30.74M).Learn more on Phathom Pharmaceuticals' institutional investors.

99.01% of Phathom Pharmaceuticals' stock is owned by institutional investors. Learn more on PHAT's institutional investor holdings.

Of the 146 institutional investors that purchased Phathom Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Jennison Associates LLC ($4.30M), Millennium Management LLC ($2.86M), Frazier Life Sciences Management L.P. ($2.36M), Wasatch Advisors LP ($1.64M), FMR LLC ($1.30M), 683 Capital Management LLC ($1.10M), and SummitTX Capital L.P. ($995.89K).

Institutional investors have bought a total of 15,596,137 shares in the last 24 months. This purchase volume represents approximately $186.96M in transactions.

Of the 42 institutional investors that sold Phathom Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($3.00M), Wasatch Advisors LP ($445.28K), Catalio Capital Management LP ($429.53K), Simplify Asset Management Inc. ($419.55K), Propel Bio Management LLC ($370K), Invesco Ltd. ($275.10K), and Royal Bank of Canada ($156.68K).

Institutional investors have sold a total of 6,223,872 shares in the last 24 months. This volume of shares sold represents approximately $92.93M in transactions.



This page (NASDAQ:PHAT) was last updated on 7/8/2026 by MarketBeat.com Staff.
From Our Partners